¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"antigen combining site"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
antigen-combining site
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen competition
Ç׿ø°æÀï
antigen diffusion constant
Ç׿øÈ®»ê»ó¼ö
antigen excess
Ç׿ø°úÀ×
antigen excess zone
Ç׿ø°úÀ×±¸¿ª
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
antigen presentation
Ç׿øÁ¦½Ã
antigen receptor
Ç׿ø¼ö¿ëü
antigen recognition
Ç׿øÀνÄ
antigen-antibody complex
Ç׿øÇ×üº¹ÇÕü
antigen-antibody interaction
Ç׿øÇ×ü»óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen receptor
Ç׿ø¼ö¿ëü
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
site
ºÎÀ§
telomeric site
¸»´ÜºÎÀ§
web site
À¥½ÎÀÌÆ®
antigen
Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø
antigen competition
Ç׿ø°æÀï
antigen excess
Ç׿ø°úÀ×
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
antigen presentation
Ç׿øÀü´Þ
antigen receptor
Ç׿ø¼ö¿ëü
antigen recognition
Ç׿øÀÎÁö
antigen analysis
Ç׿øºÐ¼®
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen binding capacity
Ç׿ø°áÇÕ´É
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
CA 50 antigen
CA 50 Ç׿ø
CA-2<
>
CA-2<<ÄÝ·ÎÀ̵åÇ׿ø>>
CD5 antigen
CD5 Ç׿ø
CEA(carcinoembryonic antigen)
žƼº¾ÏÇ׿ø
Cartwright antigen
īƮ¶óÀÌÆ®Ç׿ø
Cha antigen
Cha Ç׿ø
Chido (Ch") antigen
Chido(Ch") Ç׿ø
D antigen
D Ç׿ø
D antigen
DÇ׿ø
D-related antigen
D-°ü·ÃÇ׿ø
DP antigen
DPÇ׿ø
DQ antigen
DQÇ׿ø
DR antigen
DRÇ׿ø
Diego antigen
µð¿¡°íÇ׿ø
EB nuclear antigen(EBNA0
EB ¹ÙÀÌ·¯½º ÇÙÇ׿ø
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
binding site
°á ÇÕºÎÀ§.
corporal site
ÀڱøöÅëÀÓ½Å
definitive site
Âø»óÀÚ¸®
donor site
±Þ¿©ºÎ.
fundic site
ÀڱùٴÚÀÓ½Å
internal ribosomal entry site (IRES)
³»ºÎ ¸®º¸¼Ø °áÇÕºÎÀ§
mutational site
(µ¹¿¬)º¯ÀÌÁ¡.
packaging site
²Ù¸®±âºÎÀ§
placental site trophoblastic tumor
ŹݺÎÂøºÎÀ§ À¶¸ð»óÇǼºÁ¾¾ç
privileged site
Ưº°°Ý¸®ºÎÀ§
receptor site
¼ö¿ëüºÎÀ§.
variations of site
À§Ä¡º¯ÀÌ
web site
À¥ ½ÎÀÌÆ®
a antigen
A Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø, ±ÙÁ¢Ç׿ø(ÐÎïÈù÷ê«).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½